FMP

FMP

Enter

PROF - Profound Medical Cor...

Financial Summary of Profound Medical Corp.(PROF), Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical devic

photo-url-https://financialmodelingprep.com/image-stock/PROF.png

Profound Medical Corp.

PROF

NASDAQ

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

8.03 USD

0.23 (2.86%)

About

ceo

Dr. Arun Swarup Menawat MBA, Ph.D.

sector

Healthcare

industry

Medical - Devices

website

https://www.profoundmedical.com

exchange

NASDAQ

Description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

CIK

0001628808

ISIN

CA74319B5027

CUSIP

74319B502

Address

2400 Skymark Avenue

Phone

16474761350

Country

CA

Employee

131

IPO Date

Oct 29, 2019

Summary

CIK

0001628808

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

74319B502

ISIN

CA74319B5027

Country

CA

Price

8.03

Beta

0.79

Volume Avg.

39.71k

Market Cap

196.16M

Shares

-

52-Week

7.11-15.49

DCF

-7.43

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-5.95

P/B

-

Website

https://www.profoundmedical.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest PROF News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep